The L’Oréal Groupe unveiled its new L’Oréal Cell BioPrint at CES 2025. The Cell BioPrint is a tabletop hardware device that provides personalized skin analysis. 
 
It uses advanced proteomics, the study of how protein composition in the human body affects skin aging.
 
Barbara Lavernos, Deputy CEO in charge of Research, Innovation, and Technology at L’Oréal Groupe, said, 
 
“With skin being the largest organ, and a key part of people’s wellbeing, we are thrilled to unveil Cell BioPrint, an exclusive microfluidic lab-on-a-chip technology coupled with our century-long skin science leadership. With the Cell BioPrint device, we offer people the ability to discover deeper insights about their skin through specific biomarkers and to proactively address the beauty and longevity of their skin.”
 
The Cell BioPrint’s test process is non-invasive. Users must put a facial tape strip on one’s cheek and then place it into the buffer solution. Load the solution into the L’Oréal Cell BioPrint cartridge and insert it into the machine for analysis.
 
While the L’Oréal Cell BioPrint processes the sample, the Skin Connect device takes several images of one’s face and has users complete a short questionnaire about skin concerns and aging.
 
In five minutes, the device creates a personalized skin assessment that includes the skin’s biological age, and ingredient responsiveness, and helps customers shift from reactive to proactive skincare. 
 
L’Oréal Cell BioPrint is made possible by L’Oréal’s Longevity Integrative Science, a groundbreaking approach that reveals how mechanisms in the human body can affect skin’s appearance, and through an exclusive partnership with Korean startup NanoEnTek.
 
The L’Oréal Cell BioPrint is scheduled to pilot with a L’Oréal brand in Asia later in 2025.

Read Next